Been given any good gifts recently? (Female)

This poster draws attention to the health risks of chlamydia for women and advises on the use of condoms as a method of protection from sexually transmitted infections (STIs). It also provides contact details for the�Genito Urinary Medicine (GUM) clinics in Northern Ireland.

Been given any good gifts recently? (Male)

This poster draws attention to the health risks of chlamydia for men and advises on the use of condoms as a method of protection from sexually transmitted infections (STIs). It also provides contact details for the Genito Urinary Medicine (GUM) clinics in Northern Ireland.

Get into rubber!

This poster provides advice on the use of condoms as a method of protection from sexually transmitted infections (STIs). It also provides contact details for the�Genito Urinary Medicine (GUM) clinics in Northern Ireland.

The only thing he didn't let slip was that he had syphilis

This poster informs how syphilis can be spread through intimate contact including kissing or oral sex and how condoms can be used as a method of protection from sexually transmitted infections (STIs). It also provides contact details for the�Genito Urinary Medicine (GUM) clinics in Northern Ireland.

HIV hasn't gone away

This poster provides a reminder that HIV is still a threat to our health and that to avoid it, we should use a condom for protection. It also provides contact details for the�Genito Urinary Medicine (GUM) clinics in Northern Ireland and the Northern Ireland AIDS Helpline Tel: 0800 137 437.

Hot stuff

This poster provides information on the possible symptoms of gonorrhoea and advises on the use of condoms as a method of protection from sexually transmitted infections (STIs). It also provides contact details for the�Genito Urinary Medicine (GUM) clinics in Northern Ireland.

The only thing he didn't let slip was that he had syphilis

This poster informs how syphilis can be spread through oral sex and how condoms can be used as a method of protection from sexually transmitted infections (STIs). It also provides contact details for the�Genito Urinary Medicine (GUM) clinics in Northern Ireland.

Love machine

This poster provides advice on the use of condoms as a method of protection from unplanned pregnancy and sexually transmitted infections (STIs). It also provides contact details for the�Genito Urinary Medicine (GUM) clinics in Northern Ireland.

One of the most popular brands of sexually transmitted infection

This poster informs about chlamydia, stating that it doesn't always show symptoms and can be prevented by using a condom. It also provides updated attendance and contact details for the�Genito Urinary Medicine (GUM) clinics in Northern Ireland.

One of the most popular brands of sexually transmitted infection

This poster informs about chlamydia, stating that it doesn't always show symptoms and can be prevented by using a condom. It also provides updated attendance and contact details for the�Genito Urinary Medicine (GUM) clinics in Northern Ireland.

The only thing she didn't let slip was that she had syphilis. (For males)

This poster informs how syphilis can be spread through oral sex and how condoms can be used as a method of protection from sexually transmitted infections (STIs). It also provides updated attendance and contact details for the�Genito Urinary Medicine (GUM) clinics in Northern Ireland.

Never underestimate peace of mind (syphilis)

This leaflet explains what syphilis is and how it can be contracted through several forms of intimate contact including kissing, unprotected sex or genital contact. It explains what the possible symptoms may be like, as half of the people infected with this infection show no symptoms at all. It explains how syphilis is diagnosed and treated and how to protect yourself against catching it. Details of the�Genito Urinary Medicine (GUM) Clinics in Northern Ireland are included in the leaflet together with an explanation of the services provided by them.

Northern Ireland Point Prevalence Survey of Hospital-acquired Infections and Antimicrobial Use 2012

The PHA�coordinated Northern Ireland's participation in ECDC's National Prevalence Survey on�Hospital-Acquired Infections & on Antimicrobial Use. Hospitals in Northern Ireland participated in data collection between May and June 2012.This report provides a snapshot of the levels of hospital-acquired infections (HAI) and levels of antimicrobial use (AMU) in hospitals in Northern Ireland during 2012.There have been three previous HAI PPS surveys and the last survey was carried out in 2006. It is difficult to compare each survey as the data was collected in a different way. However, after making allowances, there was an overall drop in HAI prevalence of 18% from 2006 to 2012.The PPS data collection was undertaken by hospital teams between May and June 2012 (one hospital deferred data collection until September 2012 because of a move to a new hospital); 16 hospitals surveyed 3,992 eligible patients. The median age of all patients was 66 years. A total of 383 (10 per cent) children under 16 years of age were surveyed.�Key results from this year's survey:The prevalence of HAI was 4.2%. A total of 166 patients were diagnosed with an active HAI with 3 patients having more than one infection.When comparing ward specialties, HAI prevalence was highest for patients in adult intensive care units (ICUs) at 9.1 per cent, followed by care of the elderly wards at 5.7%.The most common types of HCAI were respiratory infections (including pneumonia and infections of the lower respiratory tract) (27.9 per cent of all infections), surgical site infections (18.9 per cent) and urinary tract infections (UTI) (11.8 per cent).Since the last PPS in 2006 there has been a reduction in MRSA infections - from 0.9 per cent �of the hospital population to less than 0.1 per cent in patients; and a five-fold reduction in C. difficile infections (from 1.1 per cent to 0.2 per cent).The prevalence of antimicrobial use was 29.5%.Most antibiotic use (60 per cent) in hospitals was in patients receiving treatment for infections which commenced in the community. Eleven percent of surgical prophylaxis was prescribed for greater than one day.��

Sexually Transmitted Infection surveillance in Northern Ireland 2014

Summary points In Northern Ireland Genito-Urinary Medicine (GUM) clinics in 2013 • New diagnoses of uncomplicated chlamydia increased by 1% ; 1,699 diagnoses in 2013 compared with 1,676 in 2012. • New diagnoses of uncomplicated gonorrhoea increased by 19%; 537 in 2013 compared with 451in 2012. • New diagnoses of genital herpes simplex (first episode) increased by 8%; 385 in 2013 compared with 357 in 2012. • New diagnoses of genital warts (first episode) decreased by 9%; 1, 989 in 2013 compared with 2190 in 2012. • New diagnoses of infectious syphilis increased by 3%; 72 in 2013 compared with �70 in 2012. �

Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans.

OBJECTIVE: The goal of this study was to investigate whether angiotensin II receptor blockers (ARBs) induce a comparable blockade of AT1 receptors in the vasculature and in the kidney when the renin-angiotensin system is activated by a thiazide diuretic. METHOD: Thirty individuals participated in this randomized, controlled, single-blind study. The blood pressure and renal hemodynamic and tubular responses to a 1-h infusion of exogenous angiotensin II (Ang II 3 ng/kg per min) were investigated before and 24 h after a 7-day administration of either irbesartan 300 mg alone or in association with 12.5 or 25 mg hydrochlorothiazide (HCTZ). Irbesartan 300/25 mg was also compared with losartan 100 mg, valsartan 160 mg, and olmesartan 20 mg all in association with 25 mg HCTZ. Each participant received two treatments with a 1-week washout period between treatments. RESULTS: The blood pressure response to Ang II was blocked by more than 90% with irbesartan alone or in association with HCTZ and with olmesartan/HCTZ and by nearly 60% with valsartan/HCTZ and losartan/HCTZ (P < 0.05). In the kidney, Ang II reduced renal plasma flow by 36% at baseline (P < 0.001). Irbesartan +/- HCTZ and olmesartan/HCTZ blocked the renal hemodynamic response to Ang II nearly completely, whereas valsartan/HCTZ and losartan/HCTZ only blunted this effect by 34 and 45%, respectively. At the tubular level, Ang II significantly reduced urinary volume (-84%) and urinary sodium excretion (-65%) (P < 0.01). These tubular effects of Ang II were only partially blunted by the administration of ARBs. CONCLUSION: These data demonstrate that ARBs prescribed at their recommended doses do not block renal tubular AT1 receptors as effectively as vascular receptors do. This observation may account for the need of higher doses of ARB for renal protection. Moreover, our results confirm that there are significant differences between ARBs in their capacity to induce a sustained vascular and tubular blockade of Ang II receptors.